CAM
XLRN

ClariVest Asset Management’s Acceleron Pharma XLRN Stock Holding History

ClariVest Asset Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-19,760
Closed -$3.4M – 842
2021
Q3 		$3.4M Sell
19,760
-1,400
-7% -$183K 0.11% 184
2021
Q2 		$2.66M Sell
21,160
-4,676
-18% -$590K 0.09% 200
2021
Q1 		$3.5M Sell
25,836
-500
-2% -$64.6K 0.12% 155
2020
Q4 		$3.37M Sell
26,336
-7,120
-21% -$835K 0.11% 156
2020
Q3 		$3.77M Buy
33,456
+21,132
+171% +$2.1M 0.12% 136
2020
Q2 		$1.17M Buy
12,324
+5,197
+73% +$501K 0.03% 302
2020
Q1 		$641K Buy
+7,127
New +$554K 0.02% 370

ClariVest Asset Management's XLRN Position: Q4 2021 in Review

ClariVest Asset Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 19,760 shares — an estimated $3.4M sold.

ClariVest Asset Management first reported a position in XLRN in Q1 2020 and held it in 7 quarters. The position peaked at $3.77M in Q3 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • ClariVest Asset Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • ClariVest Asset Management sold 19,760 Acceleron Pharma shares in Q4 2021, an estimated $3.4M.
  • ClariVest Asset Management first reported a position in Acceleron Pharma in Q1 2020 and held it in 7 quarters.
  • ClariVest Asset Management's Acceleron Pharma position peaked at $3.77M in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on ClariVest Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.